Epilepsy control in the 21st century: Leave no child behind

Epilepsia

Volumn 44, Issue 3, 2003, Pages 273-275

  Pal, Deb K ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

CHILDHOOD MORTALITY; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DISEASE CONTROL; DRUG COST; EPILEPSY; HEALTH CARE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; INDIA; MEDICAL TECHNOLOGY; NOTE; PHYSICIAN; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SOCIAL STATUS;

ANTICONVULSANTS; CHILD; COMMUNITY HEALTH AIDES; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; DRUG COSTS; EPILEPSY; HUMANS; WORLD HEALTH;

EID: 0037347238     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2003.52202.x     Document Type: Note

References (19)

1. Mather I, Linnane J, Ramaiah S. Epilepsy in less-developed countries and at home. Lancet 2001;358:672.
2. World Health Organisation. WHO/UNICEF. Primary health care (report of the International Conference on Primary Health Care. Alma-Ata, USSR: WHO, 1978.
3. Owa JA, Osinaike AI, Costello AM. Charging for health services in developing countries. Lancet 1992;340:732.
4. Ellison RE, Guvener A, Feksi G, et al. A study of approaches to antiepileptic drug treatment in four countries in the developing world. In: Dreifuss F, ed. Advances in epileptology-XVIIth: Epilepsy International Symposium. New York: Raven Press, 1989:xx-x.
5. Pal DK. Shadows and light: childhood epilepsy as a public health priority: Indian perspectives. Downloadable from Centre for International Child Health www.cich.ich.ucl.ac.uk; 2002.
6. Pal DK, Das T, Sengupta S, et al. Help-seeking patterns for children with epilepsy in rural India: implications for service delivery. Epilepsia 2002;43:904-11.
7. Radhakrishnan K, Nayak SD, Kumar SP, et al. Profile of antiepileptic pharmacotherapy in a tertiary referral center in south India: a pharmacoepidemiologic and pharmacoeconomic study. Epilepsia 1999;40:179-85.
8. Thomas SV, Sarma PS, Alexander M, et al. Economic burden of epilepsy in India. Epilepsia 2001;42:1052-60.
9. Karande SC, Dalvi SS, Kshirsagar NA. Shortcomings in the pharmacotherapy of epileptic children in Bombay, India. J Trop Pediatr 1995;41:247-9.
10. Pal DK, Das T, Sengupta S. Case-control and qualitative study of attrition in a community epilepsy programme in rural India. Seizure 2000;9:119-23.
11. Reynolds EH. ILAE/IBE/WHO Global Campaign "Out of the Shadows": global and regional developments. Epilepsia 2001;42: 1094-100.
12. World Bank. Investing in health: world development indicators. New York: Oxford University Press, 1993.
13. Adamolekun B, Mielke JK, Ball DE. An evaluation of the impact of health worker and patient education on the care and compliance of patients with epilepsy in Zimbabwe. Epilepsia 1999;40: 507-11.
14. Pal DK, Das T, Chaudhury G, et al. Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet 1998;351:19-23.
15. Mani KS, Rangan G, Srinivas HV, et al. Epilepsy control with phenobarbital or phenytoin in rural south India. Lancet 2001;357: 1316-20.
16. Shorvon SD, Farmer PJ. Epilepsy in developing countries: a review of epidemiological, sociocultural and treatment aspects. Epilepsia 1988;29(S):36-54.
17. Epping-Jordan J. Innovative care for chronic conditions: building blocks for action: global report. Geneva: WHO, 2002. Report No.: WHO/MNC/CCH/02.01.
18. Pal DK. Epilepsy control in the 21st century: hidden impact on children and families. Child Care Health Dev 2003 (in press).
19. Pal DK, Chaudhury G, Sengupta S, et al. Social integration of children with epilepsy in rural India. Soc Sci Med 2002;54: 1867-74.